OSCC微转移的发病机制及检测综述

Sukriti Paul, L. Joshi
{"title":"OSCC微转移的发病机制及检测综述","authors":"Sukriti Paul, L. Joshi","doi":"10.18231/J.JOOO.2020.031","DOIUrl":null,"url":null,"abstract":"Oral squamous cell carcinoma (OSCC) has a remarkable global incidence and equally daunting mortality rates. Despite diagnostic and therapeutic advancements, mortality and morbidity rates in patients diagnosed with oral cancer remain constant. The most fundamental prognostic marker for patients with OSCC is metastasis to cervical lymph nodes or distant organs. Micrometastasis refers to the microscopic deposits of malignant cells distinct from the primary lesion. There are several techniques for detection of micrometastasis including Immunohistochemistry (IHC), Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and serial sectioning but certain special stains that are reliable like Modified Papanicolaou stain and Toluidine can be used on serial sectioned lymph node sections to detect micrometastasis. Early recognition of micrometastatsis in OSCC especially after surgery is undeniably advantageous for the patient and aids in modifying the treatment. Micrometastasis being an essential adverse prognostic factor in oral and oropharyngeal SCC, it becomes the utmost responsibility of the clinician to inculcate various methods for its detection into future clinical trials and management strategies for better understanding and outcome of the disease. © 2020 Published by Innovative Publication. This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/)","PeriodicalId":16606,"journal":{"name":"Journal of oral medicine","volume":"27 1","pages":"140-145"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pathogenesis and detection of micrometastasis in OSCC- An overview\",\"authors\":\"Sukriti Paul, L. Joshi\",\"doi\":\"10.18231/J.JOOO.2020.031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Oral squamous cell carcinoma (OSCC) has a remarkable global incidence and equally daunting mortality rates. Despite diagnostic and therapeutic advancements, mortality and morbidity rates in patients diagnosed with oral cancer remain constant. The most fundamental prognostic marker for patients with OSCC is metastasis to cervical lymph nodes or distant organs. Micrometastasis refers to the microscopic deposits of malignant cells distinct from the primary lesion. There are several techniques for detection of micrometastasis including Immunohistochemistry (IHC), Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and serial sectioning but certain special stains that are reliable like Modified Papanicolaou stain and Toluidine can be used on serial sectioned lymph node sections to detect micrometastasis. Early recognition of micrometastatsis in OSCC especially after surgery is undeniably advantageous for the patient and aids in modifying the treatment. Micrometastasis being an essential adverse prognostic factor in oral and oropharyngeal SCC, it becomes the utmost responsibility of the clinician to inculcate various methods for its detection into future clinical trials and management strategies for better understanding and outcome of the disease. © 2020 Published by Innovative Publication. This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/)\",\"PeriodicalId\":16606,\"journal\":{\"name\":\"Journal of oral medicine\",\"volume\":\"27 1\",\"pages\":\"140-145\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-10-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of oral medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18231/J.JOOO.2020.031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of oral medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/J.JOOO.2020.031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

口腔鳞状细胞癌(OSCC)具有显著的全球发病率和同样令人生畏的死亡率。尽管诊断和治疗取得了进步,但口腔癌患者的死亡率和发病率保持不变。OSCC患者最基本的预后指标是颈部淋巴结或远处器官的转移。微转移是指不同于原发病变的恶性细胞的显微沉积。微转移的检测方法有免疫组织化学(IHC)、逆转录聚合酶链反应(RT-PCR)和连续切片等,但在连续切片的淋巴结切片上,可以使用一些可靠的特殊染色剂(如Modified Papanicolaou染色剂和甲苯胺染色剂)检测微转移。不可否认,早期识别OSCC的微转移,特别是在手术后,对患者是有利的,有助于修改治疗方案。微转移是口腔和口咽鳞状细胞癌的一个重要的不良预后因素,临床医生的最大责任是在未来的临床试验和管理策略中灌输各种检测方法,以更好地了解疾病和预后。©2020由创新出版社出版。这是一篇基于CC BY-NC许可的开放获取文章(https://creativecommons.org/licenses/by-nc/4.0/)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pathogenesis and detection of micrometastasis in OSCC- An overview
Oral squamous cell carcinoma (OSCC) has a remarkable global incidence and equally daunting mortality rates. Despite diagnostic and therapeutic advancements, mortality and morbidity rates in patients diagnosed with oral cancer remain constant. The most fundamental prognostic marker for patients with OSCC is metastasis to cervical lymph nodes or distant organs. Micrometastasis refers to the microscopic deposits of malignant cells distinct from the primary lesion. There are several techniques for detection of micrometastasis including Immunohistochemistry (IHC), Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and serial sectioning but certain special stains that are reliable like Modified Papanicolaou stain and Toluidine can be used on serial sectioned lymph node sections to detect micrometastasis. Early recognition of micrometastatsis in OSCC especially after surgery is undeniably advantageous for the patient and aids in modifying the treatment. Micrometastasis being an essential adverse prognostic factor in oral and oropharyngeal SCC, it becomes the utmost responsibility of the clinician to inculcate various methods for its detection into future clinical trials and management strategies for better understanding and outcome of the disease. © 2020 Published by Innovative Publication. This is an open access article under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/)
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信